# Portfolio State — 2026-08-09

**Calibration State:** 1.69
**Scenario probabilities:** A=19% / B=38% / C=28% / D=3% / E=9% / F=3%
**Primary driver:** Ad-hoc MLPX position review (client concern: overweight, stalled price). Ran full M03 scoring fresh: continued Hormuz closure (T1-verified, still effectively shut; Iran-Oman nearing a traffic-management deal per Aug 8 CNN but no near-term return to normal traffic) and the Fed's July 29 hawkish hold (3 dissents favoring a hike, no forward guidance) kept B dominant at 37.6%. June CPI decelerated to 3.5% (from May's 4.2%) and Q2 GDP slowed to 1.5% (from 2.1%), trimming A to 18.8% and C to 28.2%. E rose 3%->9.4% on E_check_dedollar (IMF COFER data: continued gradual dollar reserve-share decline + ongoing central bank gold accumulation) -- a judgment call worth a consistency check next session. MLPX evaluated across Primary IRA/Roth/Taxable Acc4 at current probs: blended conservative EV +4.33% (RAC 50%/IHC 50%: A +2.5/B +6.0/C +7.5/D -7.0/E -4.0/F +2.5), directive HOLD in all three, no dual-role conflict, M07 re-check PASS (AUM ~$3.55B, 13yr track record). Not dead weight by the framework's math -- B+C combined (65.8%) is structurally favorable for MLPX's role mix despite flat trailing-quarter price. 90d trailing avg $74.55 vs current $72.92 -- not price-extended.

## Open Triggers
- Iran/Hormuz chokepoint remains T1-verified active (Aug 8-9: Iran-Oman nearing a traffic-management deal per CNN, but Tehran states no near-term return to normal traffic; toll-free window expires ~Aug 17) -- C_check_chokepoint stays at 2 until a dateable de-escalation event fires
- July CPI (Aug 12, 8:30am ET) still pending -- will move B/C; June print was 3.5% YoY, decelerating from May's 4.2%
- DBMF Sec13 thesis-sustaining condition FAILED again this session (second consecutive read) -- needs real review despite position-sizing math still returning ADD
- AIPO trend signal WEAKENING, worsening on medium-term window -- relevant to client's own stated AIPO exit trigger
- CCC OAS diverging from calm HY/IG composite -- narrow, not D-triggering, but a tail-widening-first pattern worth tracking
- MOVE index 30d/90d rolling averages still uncomputable via market_get_history (series stops 2026-07-17) -- unresolved data-source gap
- Sept 30 audit: broad_market_equity_international A/B/C MEDIUM-confidence proposals pending adjudication
- XAR two-quarter procedural gate to March 2027 unchanged -- GAP-17 sign-split still unresolved
- Taxable Acc4 MLPX at 24.19% vs the account's 25% concentration cap -- only 0.81pp headroom; client's own 20% target already on the sheet would restore room
- Primary IRA/Roth target-mix feasibility shortfall found this session: portfolio_return ~0.44-0.47% vs required ~3.6-3.7% (~3.2pp gap) at current live targets -- likely SCHD's two still-PENDING §4.1 cells (healthcare_defensive_equity, consumer_defensive_equity E) given SCHD's 35% target weight; not yet root-caused
- Instrument_Classification.md §11.3 consolidated target table is stale for MLPX (30%/28%/30% IRA/Roth/Taxable vs live sheet's 20%/20%/20%) and internally inconsistent with the run_computation tool's own Taxable Acc4 narrative (claimed MLPX 25%/RSP->0% vs live sheet's MLPX 20%/RSP 5%) -- needs coding-session sync to the live Allocation sheet

## Open Decisions
- Relative IRA (...469) / Relative Roth (...466): floor check CLEAR this session -- SCHD/VYMI rotation tested and improves margin further but not required; still undecided whether to execute as a buffer against A snapping back up
- Taxable Acc4 (6668-9768): sell-down to live target (SCHD 35%/VYMI 15%/XAR 10%/RSP 5%/MLPX 20%/SGOV 15%, AIPO/DBMF->0%) status unconfirmed -- real outstanding trade volumes (~$35.7k AIPO, ~$16.6k DBMF) not yet executed per client
- DBMF: Relative IRA's 541 shares (target still 17%) has no stated exit plan, separate from the Acc4 sell-down; client said full exit 'gradually, probably next week' without specifying which position(s)
- AIPO exposure in Primary IRA (~13.6%) and Primary Roth (~23.0%) still not reviewed against the AI-bubble thesis applied to Acc4
- SCHD/VYMI dividend-sleeve logic still not evaluated for Primary IRA/Roth or Acc3
- MLPX in Taxable Acc4: client considering trimming toward the account's own 20% target for concentration-cap headroom (currently 24.19% vs 25% cap) -- informational; client executes via sheet, advisor does not pre-compute share counts

_Generated via MCP (Pattern B — Claude app)._